gms | German Medical Science

German Congress of Orthopedic and Trauma Surgery (DKOU 2017)

24.10. - 27.10.2017, Berlin

EGFL8, novel angiogenesis factor overexpresses in osteonecrosis of femoral head and promotes angiogenesis via MAPK/ERK signaling pathway

Meeting Abstract

Search Medline for

  • presenting/speaker Guoju Hong - The University of Western Australia, Guangzhou University of Chinese Medicine, Perth, Australia
  • Qiushi Wei - Guangzhou University of Chinese Meidicine, Guangzhou, China
  • Peng Chen - Guangzhou University of Chinese Meidicine, Guangzhou, China
  • Haibin Wang - Guangzhou University of Chinese Meidicine, Guangzhou, China
  • Xiaorui Han - Guangzhou University of Chinese Meidicine, Guangzhou, China
  • Wei He - Guangzhou University of Chinese Meidicine, Guangzhou, China

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2017). Berlin, 24.-27.10.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. DocIN11-861

doi: 10.3205/17dkou006, urn:nbn:de:0183-17dkou0061

Published: October 23, 2017

© 2017 Hong et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objectives: Angiogenesis-osteogenesis couple plays a pivotal role in osteonecrosis of femoral head (ONFH) for necrosis absorption and bone remodeling. The property repair function of angiogenesis in the necrosis microenvironment is considered to depend on intercellular cross-talks under angiogenesis factors modulation.

Methods: In this study, transfected EGFL8 COS-7 was used to measure the express of lysates and supernatant. ONFH rat model and patients, confirmed by micro-computed tomography (micro-CT) and histopathological examination, was used to evaluate the expression of EGFL8. Endothelial cell (SVEC) culture was used to examine the inhibitory effect of EGFL8 on vascular formation and SVEC migration. Real time PCR was employed to examine the effect of EGFL8 on the expression of osteoclast and osteoblast, the maker genes expression in micro-fracture model. The activities of JNK/p38/ERK and Akt was analyzed by Western blotting.

Results and Conclusion: In this study, we showed that the modulated function of EGF-like domain 8 (EGFL8), a member of epidermal growth factor (EGF) repeat protein superfamily in ONFH. As advanced reports, it is expressed in osteoblast lineages, and promotes endothelial cell activities. The protein expression of EGFL8 is significantly increased in vivo, the osteonecrosis sample of steroid-induce ONFH rat model. Also, high expression of EGFL8, both of gene and protein were seen in necrosis area (micro-fracture) of ONFH patients, followed by the penumbra and normal area. Addition of EGFL8 highly strengthen SVEC migration, promotes tube-like structure formation in vitro. As for signaling modulation analysis, results show that EGFL8 induces the phosphorylation of MAPK/ERK. In summary, our results demonstrate that EGFL8 expressed by osteoblasts and osteoclasts improves endothelial cell activities through integrin-mediated signaling. The study highlights the important role of EGFL8 in osteonecrosis of femoral head for regulating the angiogenesis of bone repair.